Skip to main content

Market Overview

'Welcome To Crappie Lake' Stars Luann De Lesseps, Sonja Morgan Refute Ozempic Use: 'Are You Trying To Give Us A Hint?'

Share:
'Welcome To Crappie Lake' Stars Luann De Lesseps, Sonja Morgan Refute Ozempic Use: 'Are You Trying To Give Us A Hint?'

"Welcome to Crappie Lake" stars Luann de Lesseps and Sonja Morgan deny using the ‘miracle' weight loss drug Ozempic during a recent interview, Reality Tea reports.

Amid the rising trend of using Ozempic, popularised by celebrities like the Kardashian's and Elon Musk, many others have been questioned about their choice. During their press tour for "Welcome to Crappie Lake," Luann and Sonja were asked about their association with the drug.

Luann responded, “No, we don't take Ozempic. Are you trying to give us a hint?"

Sonja, while not on Ozempic, shared her experience with 360 liposuction before filming the show. She recounted the challenges she faced due to the aftercare compression garments in the heat, leading Luann to advise her to remove them.

Other celebrities like Kyle Richards and Garcelle Beauvais have also addressed Ozempic rumors. 

Image via Shutterstock

Read Next: ‘Miracle’ Weightloss Drugs Ozempic And Mounjaro Face Lawsuit Over Alleged Gastroparesis Side Effect


Engineered by Benzinga Neuro, Edited by
Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
Learn more.


 

Related Articles

View Comments and Join the Discussion!

Posted-In: Diabetes LuAnn de LessepsBiotech Entertainment News Health Care Media General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com